Skip to main content

Pulmatrix, Inc.

Data quality: 100%
PULM
Nasdaq Manufacturing Chemicals
$1.26
▲ $0.07 (5.88%)
Mkt Cap: 4.60 M
Price
$1.26
Mkt Cap
4.60 M
Day Range
$1.22 — $1.30
52-Week Range
$1.18 — $9.37
Volume
23,535
Open $1.28
50D / 200D Avg
$2.29
45.04% below
50D / 200D Avg
$4.12
69.41% below

Quick Summary

Key Takeaways

Revenue grew 10.86% annually over 5 years — strong growth
Negative free cash flow of -5.83 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10.86%
Capital efficient — spends only 5.10% of revenue on capex

Growth

Revenue Growth (5Y)
10.86%
Above sector avg (1.82%)
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-99.87%
Below sector avg (-53.41%)
ROIC-79.01%
Net Margin-66.13%
Op. Margin-66.22%

Safety

Debt / Equity
N/A
Current Ratio19.97
Interest CoverageN/A

Valuation

PE (TTM)
-0.89
Above sector avg (-1.48)
P/B Ratio0.97
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.9 -1.5
P/B 1.0 1.6
ROE % -99.9 -53.4
Net Margin % -66.1 -41.5
Rev Growth 5Y % 10.9 1.8
D/E 0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) 3.42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10.86% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7.81 M Net Income (TTM) -5.16 M
ROE -99.87% ROA -92.72%
Gross Margin N/A Operating Margin -66.22%
Net Margin -66.13% Free Cash Flow (TTM) -5.83 M
ROIC -79.01% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 19.97
Interest Coverage N/A Asset Turnover 1.40
Working Capital 4.72 M Tangible Book Value 4.73 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.89 Forward P/E N/A
P/B Ratio 0.97 P/S Ratio 0.59
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -126.71%
Market Cap 4.60 M Enterprise Value -192,121.0
Per Share
EPS (Diluted TTM) -1.41 Revenue / Share 2.14
FCF / Share -1.60 OCF / Share -1.49
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 5.10% FCF Conversion 112.96%
SBC-Adj. FCF -6.05 M Growth Momentum -10.86

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 7.81 M 7.81 M 7.30 M 6.07 M 5.17 M
Net Income -5.16 M -9.56 M -14.12 M -18.84 M -20.17 M
EPS (Diluted) -1.41 -2.62 -3.87
Gross Profit
Operating Income -5.17 M -9.76 M -14.74 M -18.95 M -20.17 M
EBITDA
R&D Expenses 38,000.0 7.17 M 15.52 M 18.24 M 15.38 M
SG&A Expenses
D&A 106,000.0 106,000.0 134,000.0 162,000.0 169,000.0
Interest Expense 467,000.0 867,000.0 309,000.0 7,000.0
Income Tax 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4.14 M 9.94 M 33.96 M 40.95 M 58.82 M
Total Liabilities 329,000.0 996,000.0 15.96 M 9.84 M 11.37 M
Shareholders' Equity 3.81 M 8.95 M 18.00 M 31.11 M 47.45 M
Total Debt
Cash & Equivalents 4.09 M 9.52 M 19.17 M 35.63 M 53.84 M
Current Assets 4.13 M 9.92 M 20.84 M 38.15 M 54.78 M
Current Liabilities 329,000.0 929,000.0 3.91 M 5.02 M 4.44 M